Feng XiaoXiao, Li Cheng, Zheng Qishan, Qian XiaoBin G, Shao WanWen, Li YuJie, Li Wei, Yin Lu, Wang Yang, Gao QianYing
*Zhongshan Ophthalmic Center, State Key Laboratory of Ophthalmology, Sun Yat-sen University, Guangzhou, China; and †Director of Statistics Medical Research & Biometrics Center, National Center for Cardiovascular Disease, Fuwai Hospital, Beijing, China.
Retina. 2017 Nov;37(11):1989-2000. doi: 10.1097/IAE.0000000000001553.
The authors examined the differences between silicone oil and other vitreous tamponades or placebo in performing pars plana vitrectomy.
This review and meta-analysis was conducted in accordance with the PRISMA guidelines. Seven databases and the reference lists of the retrieved randomized controlled trial articles were searched to identify eligible studies. The primary outcomes were the rate of redetachment after endotamponade removal, the rate of reoperation, and poor visual acuity. The secondary outcomes were adverse events and quality of life related to postoperative position.
Ten articles (12 trials) were included. There were no significant differences between silicone oil and other agents in most of the primary and second outcomes. Only the risk of hypotony was found to be significantly lower when filling with silicone oil, compared with other agents. No trial reported the quality of life related to postoperative position.
Based on the available studies, the authors conclude that there is no significant difference in the risk of poor outcomes between pars plana vitrectomy with silicone oil and that with other vitreous tamponades with different surgical histories.
作者研究了硅油与其他玻璃体填充物或安慰剂在进行扁平部玻璃体切割术中的差异。
本综述和荟萃分析按照PRISMA指南进行。检索了七个数据库以及检索到的随机对照试验文章的参考文献列表,以确定符合条件的研究。主要结局为眼内填充物取出后视网膜再次脱离的发生率、再次手术率和视力不佳情况。次要结局为与术后体位相关的不良事件和生活质量。
纳入了10篇文章(12项试验)。在大多数主要和次要结局方面,硅油与其他药物之间没有显著差异。仅发现与其他药物相比,填充硅油时低眼压的风险显著更低。没有试验报告与术后体位相关的生活质量。
基于现有研究,作者得出结论,在有不同手术史的情况下,使用硅油进行扁平部玻璃体切除术与使用其他玻璃体填充物相比,不良结局风险没有显著差异。